ArticleTheranostics2025
CRISPR screening reveals ZNF217 as a vulnerability in high-risk B-cell acute lymphoblastic leukemia.
Xi Qin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleTheranostics2025
Xi Qin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.